Prevalence of nosocomial infections in The Netherlands, 2007-2008: Results of the first four national studies

Journal of Hospital Infection

Volumn 75, Issue 3, 2010, Pages 168-172

  van der Kooi, T I I ^a   Mannien J ^a   Wille, J C ^b   van Benthem, B H B ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Dutch Institute for Healthcare Improvement CBO   (Netherlands)

Author keywords

Antibiotic use; Device use; Hospital acquired infection; National survey; Nosocomial infection; Prevalence survey

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; CHILD; CONTROLLED STUDY; DEVICE; DISEASE SURVEILLANCE; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SURGICAL INFECTION; SURGICAL SITE INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; YOUNG ADULT;

EID: 77953541577     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.11.020     Document Type: Article

References (22)

1. Eriksen H.M., Iversen B.G., Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect 2005, 60:40-45.
2. Floret N., Bailly P., Bertrand X., et al. Results from a four-year study on the prevalence of nosocomial infections in Franche-Comte: attempt to rank the risk of nosocomial infection. J Hosp Infect 2006, 63:393-398.
3. Humphreys H., Newcombe R.G., Enstone J., et al. Four country healthcare associated infections prevalence survey 2006: risk factor analysis. J Hosp Infect 2008, 69:249-257.
4. Kritsotakis E.I., Dimitriadis I., Roumbelaki M., et al. Case-mix adjustment approach to benchmarking prevalence rates of nosocomial infection in hospitals in Cyprus and Greece. Infect Control Hosp Epidemiol 2008, 29:685-692.
5. Lyytikäinen O., Kanerva M., Agthe N., Möttönen T., Ruutu P., Finnish Prevalence Survey Study Group Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect 2008, 69:288-294.
6. Reilly J., Stewart S., Allardice G., et al. NHS Scotland national prevalence survey. Final report 2007 2007, Health Protection Scotland, Glasgow.
7. Gordts B, Vrijens F, Peeters G, et al. Nationwide investigation into the prevalence of nosocomial infections in Belgium. Abstract at ECCMID 2009.
8. Defez C., Fabbro-Peray P., Cazaban M., Boudemaghe T., Sotto A., Daurès J.P. Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital. J Hosp Infect 2008, 68:130-136.
9. Fabbro-Peray P., Sotto A., Defez C., et al. Mortality attributable to nosocomial infection: a cohort of patients with and without nosocomial infection in a French university hospital. Infect Control Hosp Epidemiol 2007, 28:265-272.
10. Goebbels E.L.P.E. Prevention of surgical infections through surveillance 2002, Dissertation, University of Utrecht, p. 101-116.
11. Hopmans T.E.M., Blok H.E.M., Troelstra A., Bonten M.J.M. Prevalence of hospital-acquired infections during successive surveillance surveys conducted at a university hospital in the Netherlands. Infect Control Hosp Epidemiol 2007, 28:459-465.
12. Erntell M, Skoog G, Cars O, et al. Changes in patterns of antimicrobial use in Swedish hospitals from 2003 to 2006 following the introduction of large-scale nationwide point prevalence studies. Abstract at ECCMID 2008.
13. European Centre for Disease Prevention and Control Annual epidemiological report on communicable diseases in Europe 2008 2008, European Centre for Disease Prevention and Control, Stockholm.
14. French Prevalence Survey Study Group Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. J Hosp Infect 2000, 46:186-193.
15. Smyth E.T.M., McIlvenny G., Enstone J.E., et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008, 69:230-248.
16. Gastmeier P., Weitzel-Kage D., Behnke M., Eckmanns T. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents 2009, 33:S19-S23.
17. Notermans D.W., Kooi T.I.I.van der, Goorhuis A., Debast S.B., Benthem B.H.B.van, Kuijper E.J. Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes. Nederl Tijdschr Geneesk 2008, 152:1937-1940.
18. Gastmeier P., Kampf G., Wischnewski N., et al. Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998, 38:37-49.
19. Sax H., Pittet D. Résultats de l'enquête nationale de prévalence des infections nosocomiales de 2004 (snip04). Swiss-NOSO 2005, 12:1-8.
20. Sax H., Pittet D., Swiss-NOSO network Interhospital differences in nosocomial infection rates. Importance of case-mix adjustment. Arch Intern Med 2002, 162:2437-2442.
21. Stichting Werkgroep Antibioticabeleid Nethmap 2003 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands 2003, SWAB, Amsterdam.
22. Stichting Werkgroep Antibioticabeleid Nethmap 2008 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands 2008, SWAB, Amsterdam.